Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00263185 · ClinicalTrials.gov registry record · Early Phase 1
High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 63
- Enrollment target
NCT00263185 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 63 participants.
The verdict
NCT00263185, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Vitamin D supplementation reduces the symptoms of muscle stiffness and joint tenderness that some patients may develop after starting therapy with Anastrozole for breast cancer.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin D
- DRUG Vitamin D
- DIETARY_SUPPLEMENT Calcium carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2005-11 |
| Est. Completion | 2009-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00263185
The ClinicalTrials.gov registry entry for NCT00263185 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00263185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00263185 about?
NCT00263185 is a clinical study titled "High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status". The purpose of this study is to determine whether Vitamin D supplementation reduces the symptoms of muscle stiffness and joint tenderness that some patients may develop after starting therapy with Anastrozole for breast cancer.
What is the current status of trial NCT00263185?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 63 participants. The study started on 2005-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00263185?
The interventions under investigation include: Placebo (OTHER), Vitamin D (DIETARY_SUPPLEMENT), Vitamin D (DRUG), Calcium carbonate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00263185?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.